Report overview
This report aims to provide a comprehensive presentation of the global market for Engineered T Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Engineered T Cells. This report contains market size and forecasts of Engineered T Cells in global, including the following market information:
Global Engineered T Cells Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Engineered T Cells market was valued at US$ 270.8 million in 2022 and is projected to reach US$ 1308.3 million by 2029, at a CAGR of 25.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tumor Infiltrating Lymphocytes Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, Gilead Sciences, Juno Therapeutics, Novartis, Oxford Biomedica and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Engineered T Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Engineered T Cells Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Engineered T Cells Market Segment Percentages, by Type, 2022 (%)
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor(CAR)
Global Engineered T Cells Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Engineered T Cells Market Segment Percentages, by Application, 2022 (%)
Hospitals
Cancer Research Centers
Clinics
Global Engineered T Cells Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Engineered T Cells Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Engineered T Cells revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Engineered T Cells revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Engineered T Cells, market overview.
Chapter 2: Global Engineered T Cells market size in revenue.
Chapter 3: Detailed analysis of Engineered T Cells company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Engineered T Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
